col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


15 Results       Page 1

 [1] 
Wiley: Biotechnology Journal
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―26 Innovative translational platforms for rapid developing clinical vaccines against COVID-19 and other infectious disease Ning Wang, Ting Wang
2 [GO] 2023―Nov―21 E and M SARS-CoV-2 membrane protein expression and enrichment with plant lipid droplets Lionel Gissot, Florent Fontaine, Zsolt Kelemen, Ousmane Dao, Isabelle Bouchez, Carine Deruyffelaere, et al. (+6)
3 [GO] 2023―Oct―19 Enhanced binding and inhibition of SARS-CoV-2 by a plant-derived ACE2 protein containing a fused mu tailpiece Sohee Lim, Hyung-Jun Kwon, Dae Gwin Jeong, Hualin Nie, Sanghee Lee, Ko Seo-rin, et al. (+6)
4 [GO] 2023―Sep―28 Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2 Laura E. Kuczynski, James R. Shallow, Matthew P. Watson, Michael L. Homsy, Thomas Svab, Ashley Gruber, et al. (+3)
5 [GO] 2023―Sep―26 Characterization and discrimination of spike protein in SARS-CoV-2 virus-like particles via surface-enhanced raman spectroscopy Munevver Akdeniz, Zakarya Al-Shaebi, Mine Altunbek, Canan Bayraktar, Alisan Kayabolen, Tugba Bagci-Onder, Omer Aydin
6 [GO] 2023―Jun―10 A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge Ming Xia, Krisangel López, Frank S. Vago, Pengwei Huang, Dawn I. Auguste, Wen Jiang, et al. (+2)
7 [GO] 2022―Jun―30 Regeneration of Capto™ Core 700 resin through high throughput and laboratory scale studies and impact on production of a SARS-CoV-2 vaccine candidate Spyridon Konstantinidis, Seth R. Reinhart, Christine Castagna, Murphy R. Poplyk, Richard R. Rustandi, Kristen L. Flor, et al. (+5)
8 [GO] 2022―Jun―03 Production of novel SARS-CoV-2 Spike truncations in Chinese hamster ovary cells leads to high expression and binding to antibodies Shiaki A. Minami, Seongwon Jung, Yihan Huang, Bradley S. Harris, Matthew W. Kenaston, Roland Faller, et al. (+3)
9 [GO] 2022―Jan―25 Designed SARS-CoV-2 receptor binding domain variants form stable monomers Miriam Klausberger, Nikolaus F. Kienzl, Gerhard Stadlmayr, Clemens Grünwald-Gruber, Elisabeth Laurent, Katharina Stadlbauer, et al. (+9)
10 [GO] 2021―Aug―11 Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies Yan Lou, Wenxiang Zhao, Haitao Wei, Min Chu, Ruihua Chao, Hangping Yao, et al. (+17)
11 [GO] 2021―May―09 Lyophilization of premixed COVID-19 diagnostic RT-qPCR reactions enables stable long-term storage at elevated temperature Michael J. Hammerling, Katherine F. Warfel, Michael C. Jewett
12 [GO] 2021―Feb―18 Detection of the SARS-CoV-2 D614G mutation using engineered Cas12a guide RNA Qingzhou Meng, Xinjie Wang, Yanqun Wang, Lu Dang, Xinyi Liu, Xiaodong Ma, et al. (+7)
13 [GO] 2021―Jan―23 Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamiana Alexandra Castilho, Jennifer Schwestka, Nikolaus F. Kienzl, Ulrike Vavra, Clemens Grünwald-Gruber, Shiva Izadi, et al. (+10)
14 [GO] 2020―May―18 Molecular Targets for the Testing of COVID-19 Suh Kuan Yong, Ping-Chia Su, Yuh-Shyong Yang
15 [GO] 2020―Apr―18 Progress and Concept for COVID-19 Vaccine Development Suh-Chin Wu
 [1] 

15 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec